Q1 2024: Thoughtful execution of legal strategy, elevation of industry reputation, and more

ACCESS 2023 REPORTS

As the dietary supplement and functional food industry faces impending age restrictions on its products in New York, with other states also seeking to fill perceived gaps in regulation, and ongoing scrutiny from critics over melatonin and gummy supplements, CRN’s thoughtful and expert execution of work driven by our board-developed strategic plan was well underway in the first quarter. This page includes links to the content referenced in our Q1 2024 Industry Impact printable one-page summary.

 

Following is a brief recap of CRN’s impactful work for its members during Q1 in each of the areas of our strategic plan: 

Expanding Self-Regulatory Initiatives


Influencing Public Policy


Improving Consumer Access


Cultivating Positive Public Perceptions


Expanding Membership and Educational Offerings

 

Review our 2023 annual report 

Hear from the CRN senior staff team and see how their expertise enhanced our members’ position in the marketplace.

 

Catch up on thought leadership 

See bylined articles from CRN President & CEO Steve Mister: 

 

Save the date for our annual events

Experience a new format with something for everyone on your teams.

 

CONVERGENCE '24

 

Science in Session and WellComms events

 

Go deeper:

CRN and its members lead in establishing self-regulatory initiatives demonstrating the highest quality and ethical standards

CRN’s Board of Directors recently approved new guidelines for the labeling of gummy dietary supplements, along with guidelines for supplements and functional food sold on e-commerce platforms, and important updates to the guidelines for melatonin-containing dietary supplements marketed for sleep support—all developed by the association’s working groups of members and staff. Adopting these guidelines, the latest in a set of self-regulatory initiatives, underscores CRN members’ commitment to delivering products that exceed consumer expectations and regulator requirements.

Learn more about CRN’s Economic Impact Study (EIS)  www.crnusa.org/impact

The EIS, with newly updated data, is a vital part of the industry’s advocacy efforts as it allows CRN to specifically quantify and communicate to legislators and constituents the financial importance of supplement companies within each legislative district. 

 

Meet the industry leaders among our member companies www.crnusa.org/Profiles-in-Leadership

 

And the technical experts behind the products, ingredients, and services www.crnusa.org/CRN-Experts-Explain